[Fig. 2](#pone.0118636.g001){ref-type="fig"} is incorrect. The y-axis is incorrectly labeled in [Fig. 2G](#pone.0118636.g001){ref-type="fig"}. The authors have provided a corrected version here.

![Unusually rapid biodistribution of radiolabeled HRG.\
A. Blood kinetics of ^125^l-albumin, ^125^l-hHRG and ^125^l-mHRG in C57BL/6 mice. (n = 4/time point). B. Biodistribution of ^125^l-hHRG in selected C57BL/6 mouse organs. C. Percentage of radioactivity in blood plasma, associated with a high molecular-weight fraction (\>5 kDa). D. Biodistribution of ^125^l-mHRG in selected organs of naive C57BL/6 mice. E. Liver uptake of ^125^l-mHRG and ^125^l-mHRG. F. Biodistribution of ^125^l-mHRG in selected organs of T241 fibrosarcoma-bearing C57BL/6 mice. G. TCA-precipitable ^125^l-radioactivity in plasma after 2 h of circulation in naive and tumor-bearing mice injected with ^125^l-mHRG.](pone.0118636.g001){#pone.0118636.g001}

The [Fig. 4](#pone.0118636.g002){ref-type="fig"} legend is incorrect. The third sentence of the [Fig. 4](#pone.0118636.g002){ref-type="fig"} legend should have been omitted. The complete, correct [Fig. 4](#pone.0118636.g002){ref-type="fig"} legend is:

![HRG detected by IHC of CRC tumor tissue arrays.\
A. Scoring of HRG IHC signals associated with inflammatory cells in CRC arrays from strong to no signal. Statistical analysis; p\<0.05 was considered significant. B. Scoring of HRG IHC signals associated with vessels, as above. C. Upper and middle row of panels: Representative images of the HRG IHC signals from the indicated categories at 20× magnification. Lower row of panels: Representative images of the HRC IHC signals in CRC at 60× magnification. Arrows indicate typical vessel-associated HRG signals in normal colorectal tissue (left) and in inflammatory cells in normal tissue (middle) and in stage 2 CRC (right).](pone.0118636.g002){#pone.0118636.g002}
